Lesage Anne
Lesage Anne, CED, reported a transaction classified as exercise at Pharvaris N.V. involving 8000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 15000.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 10, 2026
- Filing date
- Sep 14, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
PHVS price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-390119 Stock Option (Right to Buy)
- Transaction date
- Sep 10, 2026 Filed Sep 14, 2026, 04:29 PM · 4d delay
- Shares
- 8,000 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 15,000 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-20 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Early Development
- F1
This is a scheduled exercise and sale from 10b5-1 trading plan.
- F2
The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection wit…
Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3
25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.
0 other transactions
0 recent txs